phrykt

Viatris (VTRS) debt: $14.4B

Viatris had $14.4B of long-term debt on Dec 31, 2025, including the part due within a year, up 2.6% from $14B a year earlier.

From Viatris's filings with the SEC · Read the filing · VTRS stock page

Viatris debt by year

$21.6B2021$19.3B2022$18.1B2023$14B2024$14.4B2025

#122 of 2,129 US companies by debt · See the full ranking

Year endedDebtChange
Dec 31, 2025$14.4B+3%
Dec 31, 2024$14B-23%
Dec 31, 2023$18.1B-6%
Dec 31, 2022$19.3B-11%
Dec 31, 2021$21.6B–

Debt of similar companies

Companies in the same industry as Viatris, by SEC industry code, with the closest debt. Each name opens the same page for that company.

CompanyDebt, latest yearYear ended
Bausch Health Companies$20.8BDec 31, 2025
Viatris$14.4BDec 31, 2025
Abbott Laboratories$12.9BDec 31, 2025
Zoetis$9BDec 31, 2025
Royalty Pharma$9BDec 31, 2025
Organon$8.6BDec 31, 2025
Jazz Pharmaceuticals$5.4BDec 31, 2025

Questions and answers

What is Viatris's debt?

Viatris had $14.4B of long-term debt on Dec 31, 2025, including the part due within a year, up 2.6% from $14B a year earlier.

Numbers as reported in Viatris's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology